Lainie Jones Comprehensive Cancer Survivorship Act of 2026

Hozzl · 2026-06-04T03:08:36Z

Explore the details of House Bill 8839 Lainie Jones Comprehensive Cancer Survivorship Act of 2026 currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on undefined. Stay informed on legislative developments.

6/4/2026, 3:08 AM

Summary of Bill HR 8839

H.R. 8839, introduced in the 119th Congress on May 14, 2026, aims to address the health needs of cancer survivors across the care continuum, spanning from diagnosis through treatment and posttreatment. The bill focuses on enhancing survivorship, treatment, transition to recovery, quality of life, palliative care, and long-term health outcomes for survivors. It proposes the development of a minimum standard of care for cancer survivorship that is inclusive of all types of cancer, survivors' backgrounds, and forthcoming survivorship needs, with the goal of improving overall survivor well-being and quality of care.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill HR 8839

Bill HR 8839 is currently in the status of Bill Introduced since May 14, 2026. Bill HR 8839 was introduced during Congress 119 and was introduced to the House on May 14, 2026. Bill HR 8839's most recent activity was Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. as of May 14, 2026

Bipartisan Support of Bill HR 8839

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill HR 8839

Primary Policy Focus

Alternate Title(s) of Bill HR 8839

To address the health of cancer survivors and unmet needs that survivors face through the entire continuum of care from diagnosis through active treatment and posttreatment, in order to improve survivorship, treatment, transition to recovery and beyond, quality of life and palliative care, and long-term health outcomes, including by developing a minimum standard of care for cancer survivorship, irrespective of the type of cancer, a survivor's background, or forthcoming survivorship needs, and for other purposes.